According to a report by CSPdaily News on June 26, it was revealed that NJOY, a subsidiary of Altria (Altria Group, Inc.), has expanded its sales network to over 80,000 retail stores in the first quarter of 2024. The company recently emphasized that they expect to "expand to approximately 100,000 retail stores by the end of the year.
NJOY continues to roll out its first retail trade program, aimed at helping the brand achieve optimal visibility and product placement in the retail market.
This expansion also comes with the U.S. Food and Drug Administration (FDA) granting marketing authorization to NJOY LLC for four menthol-flavored e-cigarette products, including NJOY ACE Pod Menthol 2.4%, NJOY ACE Pod Menthol 5%, NJOY DAILY Menthol 4.5%, and NJOY DAILY EXTRA Menthol 6%. This event marks the first time that the FDA has authorized non-tobacco flavored e-cigarette products.
NJOY CEO Shannon Leistra stated,
With the addition of NJOY menthol e-cigarette products, we now have a unique FDA-authorized product lineup to support adult smokers transitioning to smoke-free alternatives. We believe these marketing authorizations demonstrate the quality of NJOY products and the strength of evidence supporting the authorized NJOYmint e-cigarette products.
The senior vice president of regulatory affairs at the Aochiya Customer Service Company, Paige Magness, stated that...
The FDA has approved NJOY menthol-flavored e-cigarette product, providing a regulated alternative for adult smokers and e-cigarette users to replace the currently available illegal flavored disposable e-cigarette products on the market. We believe the marketing approval of NJOY mint is a positive outcome for public health.
Click on the text to continue reading:
Altria submits on! PLUS nicotine pouch PMTA application, covering three new flavors.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
